Pharmacologic blockade of JAK1/JAK2 reduces GvHD and preserves the graft-versus-leukemia effect

Authors

Jaebok Choi, Washington University School of Medicine in St. LouisFollow
Matthew L. Cooper, Washington University School of Medicine in St. LouisFollow
Bader Alahmari, Washington University School of Medicine in St. Louis
Julie Ritchey, Washington University School of Medicine in St. Louis
Lynne Collins, Washington University School of Medicine in St. LouisFollow
Matthew Holt, Washington University School of Medicine in St. Louis
John F. DiPersio, Washington University School of Medicine in St. LouisFollow

Journal

PLoS One

Publication Date

2014

Volume

9

Issue

10

Inclusive Pages

e109799

Document Type

Open Access Publication

DOI

10.1371/journal.pone.0109799

Rights and Permissions

Choi J, Cooper ML, Alahmari B, Ritchey J, Collins L, et al. (2014) Pharmacologic blockade of JAK1/JAK2 reduces GvHD and preserves the graft-versus-leukemia effect. PLoS ONE 9(10): e109799. doi: 10.1371/journal.pone.0109799

Recommended Citation

Choi, Jaebok; Cooper, Matthew L.; Alahmari, Bader; Ritchey, Julie; Collins, Lynne; Holt, Matthew; and DiPersio, John F., "Pharmacologic blockade of JAK1/JAK2 reduces GvHD and preserves the graft-versus-leukemia effect." PLoS One. 9, 10. e109799. (2014).
https://digitalcommons.wustl.edu/open_access_pubs/3407